R. Andrew Morgan is Vice President of Quality Operations and Site
Manager for Genzyme Corporation, Middleton. Prior to the acquisition
of Bone Care International by Genzyme, Mr. Morgan was the Vice President
of Regulatory-Quality and Pharmaceutical Sciences for Bone Care.
Before joining Bone Care Mr. Morgan was the Director of Regulatory
Affairs at Celltech Pharmaceuticals in Rochester NY.